Uncategorized pages

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. 2009 Profile Template Sketch
  2. 2012 Call Summaries
  3. 2013 Call Summaries
  4. 2014 Call Summaries
  5. 2015 Call Summaries
  6. 2016 Call Summaries
  7. 2019
  8. 2020
  9. 2021
  10. 2022-01-18 Process Committee Agenda
  11. 2022-02-01 Process Committee Agenda
  12. 2022-02-15 Process Committee Agenda
  13. 2022-03-01 Process Committee Agenda
  14. 2022-03-15 Process Committee Agenda
  15. 2022-04-05 Process Committee Agenda
  16. 2022-05-03 Process Committee Agenda
  17. 2022-05-17 Process Committee Agenda
  18. 2022-06-21 Process Committee Agenda
  19. 2022-07-05 Process Committee Agenda
  20. 2022-07-19 Process Committee Agenda
  21. 2022-08-02 Process Committee Agenda
  22. 2022-08-16 Process Committee Agenda
  23. 2022-09-06 Process Committee Agenda
  24. AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte
  25. AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte
  26. ARCHIVE
  27. ASFNR Materials - Abstract for Review
  28. ASL Meeting Summaries Archive
  29. About QIBA
  30. Acquisition Protocols Technical Subcommittee
  31. Additional letters of support can be found here
  32. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  33. Alzheimer's Disease PET Archive
  34. Ambition Levels for Collaboration
  35. Archive
  36. Archive - Initial Target Selection and Roadmap
  37. Archive - Lung Density
  38. Archive for Lung Nodule Assessment in CT Screening Draft Profiles
  39. Archive for previously known QIBA Modality Committees
  40. Archived: 2009 COPD/Asthma Call Summaries
  41. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  42. Archived: 2010 COPD/Asthma Call Summaries
  43. Archived: 2011 COPD/Asthma Call Summaries
  44. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  45. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  46. Archived: 2012 QIBA US SWS Technical Committee call summaries
  47. Archived: 2012 fMRI Reproducibility Call Summaries
  48. Archived: 2013 fMRI Bias WG Call Summaries
  49. Archived: 2014 fMRI Bias WG Call Summaries
  50. Archived: 2016 Lung Density BC Call Summaries
  51. Archived: fMRI Bias WG Call Summaries
  52. Archived: fMRI Reproducibility Call Summaries
  53. Archived "What is a Profile?" description as of 08.19.2011
  54. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  55. Archived - 2011 fMRI Reproducibility Call Summaries
  56. Archived DCE-MRI Profiles
  57. Archived Versions
  58. Archived Versions of QIBA Vol CT - Group 3A draft documents
  59. Assessment Procedure Guidance
  60. Atherosclerosis Biomarkers Profile Draft Archive
  61. Balloting Process
  62. Bobby test
  63. CEUS BC Call Summaries
  64. CEUS Task Force (TF) Call Summaries
  65. COPD Group Call Summaries
  66. CTV-AD Considerations for Future Editions
  67. CT Acquisition Protocol Groundwork
  68. CT Angiography Biomarker Ctte
  69. CT Angiography Call Summaries Archive
  70. CT Angiography Profile Draft Archive
  71. CT Coordinating Committee
  72. CT Draft Proffered Protocols
  73. CT Small Lung Nodule Biomarker Ctte
  74. CT Volumetry BC Call Summaries Archive
  75. CT Volumetry Biomarker Ctte
  76. Call Agenda Topics
  77. Call Summaries
  78. Call Summaries Archive
  79. Catalog
  80. Change Tracking and File Naming
  81. Claim Confirmation Process
  82. Claim Guidance
  83. Claim Language/Detail
  84. Clinical Applications and Biological Targets Subcommittee
  85. Clinical Sites
  86. Clinical Trial Planning
  87. Clinical Trials Collaboration
  88. Columbia University Medical Center
  89. Combined: System Dependencies & Phantom Development Subcommittees
  90. Combined Nuclear Medicine Biomarker Committee Call Summaries
  91. Comment Resolutions
  92. Committee Organization
  93. Committee Procedures
  94. Committee Sunset Process
  95. Committee on Image Archives
  96. Committee on Open Image Archives
  97. Committees
  98. Communications Committee
  99. Conformity Assessment
  100. Consensus Process
  101. Consensus Protocols
  102. CoreLab Partners, Inc.
  103. CoreLab Partners, Inc., Round-2
  104. Covariates Rationale
  105. DCE-MRI BC Call Summaries Archive
  106. DCE-MRI Project Page
  107. DCE MRI Biomarker Ctte
  108. DSC-MRI Call Summaries Archive
  109. DSC MRI Biomarker Ctte
  110. DTI MRI Biomarker Ctte
  111. DWI Literature Review
  112. DWI MR BC Call Summaries Archive
  113. DWI MR Biomarker Ctte
  114. DWI Profile Development Archive
  115. DWI Profile Draft Archive
  116. Dana-Farber Cancer Institute
  117. David Geffen School of Medicine at UCLA, Department of Radiology
  118. David Geffen School of Medicine at UCLA, Department of Radiology,Round-2
  119. Dept of Research Scatch Page
  120. Digital Reference Objects-Images
  121. Document Archive
  122. Documents / Call Summaries
  123. Dr Tucker's New Test Page
  124. Draft Consensus Protocols
  125. Draft New Main Page
  126. Draft Proffered Protocols
  127. Duke Brain Imaging and Analysis Center
  128. Duke University
  129. Duke University Medical Center
  130. Education
  131. Example Use Case for Open Image Archives
  132. Example Use Case for Open Image archives
  133. Executive Committee
  134. Executive Committee Call Summaries Archive
  135. Expressing Requirements
  136. FDG-PET/CT UPICT Template - (Editable)
  137. FDG-PET Archive
  138. FDG-PET Biomarker Ctte
  139. FDG-PET CT Template
  140. FDG-PET Call Summaries Archive
  141. FDG-PET Reference Material
  142. FMRI
  143. FMRI-DICOM WG Call Summaries
  144. FMRI Biomarker Ctte
  145. FMRI Call Summaries
  146. FMRI Call Summaries Archive
  147. FMRI Project Page
  148. FMRI Working Documents Archive
  149. FMRI moc profile
  150. Fmri PubMed search
  151. Follow-up Editorial
  152. Fused Images
  153. Ground Truth Strategy
  154. Groundwork and Profiling
  155. Group 3A Call Summaries Archive
  156. Guidance Document Process
  157. How To's
  158. How to Create a Google Doc
  159. How to Upload Documents to the UPICT Library
  160. How to Write a Profile
  161. How to use QIBA Profiles
  162. I-123 Biomarker Committee
  163. ISMRM/QIBA PDFF Biomarker Ctte
  164. Industry
  165. Initial Target Selection
  166. Invitation to Participate
  167. Joe's test
  168. Johns Hopkins Univ School of Medicine
  169. Johns Hopkins University School of Medicine
  170. Johns Hopkins University School of Medicine, Round-2
  171. Julie's COPD archive
  172. Julie's test
  173. Julie's test page
  174. List of Certified Conformant Users (QIBA Tested)
  175. List of Registered Conformant Users (Self-attestation
  176. List of Registered Conformant Users (Self-attestation)
  177. Lung Density/COPD BC Call Summaries Archive
  178. Lung Density BC Call Summaries
  179. Lung Density Biomarker Ctte
  180. Lung Nodule Assessment in CT Screening Call Summary Archive
  181. MRE BC Call Summaries Archive
  182. MRE Biomarker Committee Call Summaries
  183. MRE Biomarker Ctte
  184. MRE Profile
  185. MR Acquisition Protocols
  186. MR Archive
  187. MR Coordinating Committee
  188. MR Draft Proffered Protocols
  189. MSK Biomarker Committee Call Summaries
  190. MSK Biomarker Committee Call Summaries Archive
  191. MSK Biomarker Ctte
  192. Main Page
  193. Maintenance Process
  194. Medical College of Wisconsin
  195. Metrology Committee
  196. Metrology Committee Call Summaries Archive
  197. Moc-up page
  198. Moc technical committee
  199. Modality Committee Archive
  200. Monthly FDG-PET Call Summaries
  201. Myocardial Blood Flow Biomarker Committee
  202. NIST
  203. NM Coordinating Committee
  204. New Protocol Here
  205. Normalization Process
  206. Orphan Documents
  207. PDFF Biomarker Committee Call Summaries
  208. PDFF Biomarker Committee Call Summaries Archive
  209. PDFF Biomarker Ctte
  210. PDF BC Call Summaries Archive
  211. PET Amyloid BC Call Summaries Archive
  212. PET Amyloid Biomarker Ctte
  213. PET Myocardial Blood Flow Biomarker Committee
  214. PET Myocardial Blood Flow Call Summaries
  215. PET Myocardial Blood Flow Call Summaries Archive
  216. PET Tau Biomarker Committee
  217. PUBLIC COMMENT WORK PAGE
  218. Perfusion, Diffusion and Flow-MRI Biomarker Ctte
  219. Perlman Advisory Group
  220. Phantom Development
  221. Phantom Development Subcommittee
  222. Phantom Development Technical Subcommittee
  223. Phantom Protocol & Data Analysis
  224. Phantoms And Tests Subcommittee
  225. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
  226. Pilot Conformance Projects Under Development
  227. Process
  228. Process Committee Agenda Archive
  229. Process Committee Call Summaries
  230. Process Committee Call Summaries Archive
  231. Process Coordinating Committee
  232. Process Education
  233. Proffered Protocols
  234. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting
  235. Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
  236. Profile: CT Lung Nodule Response
  237. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes
  238. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
  239. Profile: FDG-PET Whole Body
  240. Profile Conformance
  241. Profile Development
  242. Profile Editions
  243. Profile Strategy for Vol CT
  244. Profile drafts
  245. Profiles
  246. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility
  247. Project 1a: Inter-scanner/ Inter-clinic Comparison of Reader Nodule Sizing in CT Imaging of a Phantom
  248. Project 2a: Assessing Measurement Variability of Lung Lesions in Patient Data Sets
  249. Project 2a: Assessing Measurement Variability of Lung Lsions in Patient Data Sets
  250. Projects

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://qibawiki.rsna.org/index.php/Special:UncategorizedPages"